At Patient-led Clinical Trials 2017, patients will lead the way. Pharma knows that clinical trials rely on patient participation, and that greater involvement delivers much more value and efficiency. Patients know that clinical trials help them to access and develop more effective treatments. But despite this mutual need, pharma has found it hard to recruit and retain volunteers, while patients find it difficult to access clinical trials.
At this event in London, representatives from both patient advocacy groups and early adopters of patient-centric trials will co-operate to deliver workable advice on improving your trials in order to facilitate better outcomes and greater returns. From using the social tools at your disposal to raise awareness, to addressing the trust, location and regulatory factors which harm volunteer retention, you’ll receive the strategic information you need to plan patient-led trials which will improve and save lives.
By working together to increase trust and transparency, pharma and patient advocates will be fully equipped to produce more efficient clinical trials which will deliver more effective treatments for a host of serious and life-limiting conditions.